{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:28:25Z","timestamp":1724862505129},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,10,10]],"date-time":"2009-10-10T00:00:00Z","timestamp":1255132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00109-009-0534-4","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T01:37:02Z","timestamp":1255052222000},"page":"1105-1110","source":"Crossref","is-referenced-by-count":15,"title":["Cancer stem cells\u2014clinical relevance"],"prefix":"10.1007","volume":"87","author":[{"given":"Richard J.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,10]]},"reference":[{"key":"534_CR1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1073\/pnas.58.4.1468","volume":"58","author":"PJ Fialkow","year":"1967","unstructured":"Fialkow PJ, Gartler SM, Yoshida A (1967) Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 58:1468\u20131471","journal-title":"Proc Natl Acad Sci USA"},{"key":"534_CR2","first-page":"411","volume":"46","author":"CH Park","year":"1971","unstructured":"Park CH, Bergsagel DE, McCulloch EA (1971) Mouse myeloma tumor stem cells: a primary cell culture assay. J Natl Cancer Inst 46:411\u2013422","journal-title":"J Natl Cancer Inst"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood.V81.11.2898.2898","volume":"81","author":"A Bedi","year":"1993","unstructured":"Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ (1993) BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 81:2898\u20132902","journal-title":"Blood"},{"key":"534_CR4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang TC-CJ, Minden M, Paterson B, Caligiuri MA, Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645\u2013648","journal-title":"Nature"},{"key":"534_CR5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","volume":"87","author":"C Sirard","year":"1996","unstructured":"Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M et al (1996) Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87:1539\u20131548","journal-title":"Blood"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2005-06-2517","volume":"107","author":"CA Huff","year":"2006","unstructured":"Huff CA, Matsui W, Smith BD, Jones RJ (2006) The paradox of response and survival in cancer therapeutics. Blood 107:431\u2013434","journal-title":"Blood"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells\u2013perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339\u20139344","journal-title":"Cancer Res"},{"key":"534_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730\u2013737","journal-title":"Nat Med"},{"key":"534_CR9","doi-asserted-by":"crossref","unstructured":"Refaeli Y, Bhoumik A, Roop DR, Ronai ZA (2009) Melanoma-initiating cells: a compass needed. EMBO Rep. doi: 10.1038\/embor.2009.184","DOI":"10.1038\/embor.2009.184"},{"key":"534_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756\u2013760","journal-title":"Nature"},{"key":"534_CR11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","volume":"68","author":"W Matsui","year":"2008","unstructured":"Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, McNiece I, Lin L, Ambinder RF, Peacock C et al (2008) Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 68:190\u2013197","journal-title":"Cancer Res"},{"key":"534_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC et al (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100:672\u2013679","journal-title":"J Natl Cancer Inst"},{"key":"534_CR13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/djh095","volume":"96","author":"RJ Jones","year":"2004","unstructured":"Jones RJ, Matsui WH, Smith BD (2004) Cancer stem cells: are we missing the target? J Natl Cancer Inst 96:583\u2013585","journal-title":"J Natl Cancer Inst"},{"key":"534_CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1142596","volume":"317","author":"PN Kelly","year":"2007","unstructured":"Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317:337","journal-title":"Science"},{"key":"534_CR15","first-page":"75","volume":"20","author":"SJ Horning","year":"1993","unstructured":"Horning SJ (1993) Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 20:75\u201388","journal-title":"Semin Oncol"},{"key":"534_CR16","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.2004.05.111","volume":"22","author":"BG Durie","year":"2004","unstructured":"Durie BG, Jacobson J, Barlogie B, Crowley J (2004) Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials. J Clin Oncol 22:1857\u20131863","journal-title":"J Clin Oncol"},{"key":"534_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Facon T, Ifrah N et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med New 335:91\u201397","journal-title":"N Engl J Med New"},{"key":"534_CR18","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875\u20131883","journal-title":"N Engl J Med"},{"key":"534_CR19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.2005.04.5807","volume":"24","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Kyle RA, Anderson KC, Greipp PR, Lazarus HM, Hurd DD, McCoy J, Dakhil SR, Lanier KS, Chapman RA et al (2006) Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. J Clin Oncol 24:929\u2013936","journal-title":"J Clin Oncol"},{"key":"534_CR20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.md.0000173272.71949.a1","volume":"84","author":"V Levy","year":"2005","unstructured":"Levy V, Katsahian S, Fermand JP, Mary JY, Chevret S (2005) A meta-analysis on data from 575 patients with multiple myeloma randomly assigned to either high-dose therapy or conventional therapy. Medicine (Baltimore) 84:250\u2013259","journal-title":"Medicine (Baltimore)"},{"key":"534_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","volume":"13","author":"J Koreth","year":"2007","unstructured":"Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP III (2007) High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transplant 13:183\u2013196","journal-title":"Biol Blood Marrow Transplant"},{"key":"534_CR22","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.2004.12.082","volume":"22","author":"CM Rocha Lima","year":"2004","unstructured":"Rocha Lima CM, Green MR, Rotche R, Miller WH Jr, Jeffrey GM, Cisar LA, Morganti A, Orlando N, Gruia G, Miller LL (2004) Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. J Clin Oncol 22:3776\u20133783","journal-title":"J Clin Oncol"},{"key":"534_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11934-003-0074-3","volume":"4","author":"D Trump","year":"2003","unstructured":"Trump D, Lau YK (2003) Chemotherapy of prostate cancer: present and future. Curr Urol Rep 4:229\u2013232","journal-title":"Curr Urol Rep"},{"key":"534_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"534_CR25","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","volume":"103","author":"WH Matsui","year":"2004","unstructured":"Matsui WH, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ (2004) Characterization of clonogenic multiple myeloma cells. Blood 103:2332\u20132336","journal-title":"Blood"},{"key":"534_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00002371-200201000-00008","volume":"25","author":"SP Treon","year":"2002","unstructured":"Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L et al (2002) CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. J Immunother 25:72\u201381","journal-title":"J Immunother"},{"key":"534_CR27","unstructured":"Huff CA, Wang Q, Rogers K, Jung M, Borrello IM, Jones RJ, Matsui W (2008) Correlation of clonogenic cancer stem cell growth with clinical outcomes in multiple myeloma (MM) patients undergoing treatment with high dose cyclophosphamide and rituximab. Proc AACR Late Breaking Abstract: LB:87"},{"key":"534_CR28","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","volume":"106","author":"CJ Creighton","year":"2009","unstructured":"Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI et al (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106:13820\u201313825","journal-title":"Proc Natl Acad Sci USA"},{"key":"534_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.2005.05606.x","volume":"130","author":"GR Angstreich","year":"2005","unstructured":"Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith BD, Jones RJ (2005) Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors. Br J Haematol 130:373\u2013381","journal-title":"Br J Haematol"},{"key":"534_CR30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105\u2013111","journal-title":"Nature"},{"key":"534_CR31","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1038\/sj.onc.1207948","volume":"23","author":"L Harrington","year":"2004","unstructured":"Harrington L (2004) Does the reservoir for self-renewal stem from the ends? Oncogene 23:7283\u20137289","journal-title":"Oncogene"},{"key":"534_CR32","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock CD, Wang Q, Gesell GS, Corcoran-Schwarz IM, Jones E, Kim J, Devereux WL, Rhodes JT, Huff CA, Beachy PA et al (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 104:4048\u20134053","journal-title":"Proc Natl Acad Sci USA"},{"key":"534_CR33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2005.11.020","volume":"123","author":"LY Hao","year":"2005","unstructured":"Hao LY, Armanios M, Strong MA, Karim B, Feldser DM, Huso D, Greider CW (2005) Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123:1121\u20131131","journal-title":"Cell"},{"key":"534_CR34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0268-960X(03)00020-1","volume":"17","author":"I Dokal","year":"2003","unstructured":"Dokal I, Vulliamy T (2003) Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev 17:217\u2013225","journal-title":"Blood Rev"},{"key":"534_CR35","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ejca.2006.01.040","volume":"42","author":"Z Ju","year":"2006","unstructured":"Ju Z, Rudolph KL (2006) Telomeres and telomerase in cancer stem cells. Eur J Cancer 42:1197\u20131203","journal-title":"Eur J Cancer"},{"key":"534_CR36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0092-8674(00)80761-8","volume":"97","author":"RA Greenberg","year":"1999","unstructured":"Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW, DePinho RA (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2\/3) cancer-prone mouse. Cell 97:515\u2013525","journal-title":"Cell"},{"key":"534_CR37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/88871","volume":"28","author":"KL Rudolph","year":"2001","unstructured":"Rudolph KL, Millard M, Bosenberg MW, DePinho RA (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28:155\u2013159","journal-title":"Nat Genet"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0534-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-009-0534-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-009-0534-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T22:06:34Z","timestamp":1590185194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-009-0534-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,10]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s00109-009-0534-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,10]]}}}